Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis.
de Groot EL, Ossewaarde-van Norel J, de Boer JH, Hiddingh S, Bakker B, van Huet RAC, Ten Dam-van Loon NH, Thiadens AAHJ, Meester-Smoor MA, de Jong-Hesse Y, Los LI, den Hollander AI, Boon CJF, Kiemeney LA, van Eijk KR, Bakker MK, Hoyng CB, Kuiper JJW. de Groot EL, et al. Among authors: de jong hesse y. JAMA Ophthalmol. 2023 Aug 1;141(8):737-745. doi: 10.1001/jamaophthalmol.2023.2557. JAMA Ophthalmol. 2023. PMID: 37410486 Free PMC article.
Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry.
Runhart EH, Dhooge P, Meester-Smoor M, Pas J, Pott JWR, van Leeuwen R, Kroes HY, Bergen AA, de Jong-Hesse Y, Thiadens AA, van Schooneveld MJ, van Genderen M, Boon C, Klaver C, van den Born LI, Cremers FPM, Hoyng CB. Runhart EH, et al. Among authors: de jong hesse y. Acta Ophthalmol. 2022 Jun;100(4):395-402. doi: 10.1111/aos.14996. Epub 2021 Aug 25. Acta Ophthalmol. 2022. PMID: 34431609 Free PMC article.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: de jong hesse y. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
Extending the Spectrum of EYS-Associated Retinal Disease to Macular Dystrophy.
Pierrache LHM, Messchaert M, Thiadens AAHJ, Haer-Wigman L, de Jong-Hesse Y, van Zelst-Stams WAG, Collin RWJ, Klaver CCW, van den Born LI. Pierrache LHM, et al. Among authors: de jong hesse y. Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2049-2063. doi: 10.1167/iovs.18-25531. Invest Ophthalmol Vis Sci. 2019. PMID: 31074760
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
van Asten F, Evers-Birkenkamp KU, van Lith-Verhoeven JJ, de Jong-Hesse Y, Hoppenreijs VP, Hommersom RF, Scholten AM, Hoyng CB, Klaver JH; HELIOS study group. van Asten F, et al. Acta Ophthalmol. 2015 Mar;93(2):126-33. doi: 10.1111/aos.12610. Epub 2014 Dec 9. Acta Ophthalmol. 2015. PMID: 25488348 Free article.
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.
van Asten F, de Jong-Hesse Y, van Lith-Verhoeven JJC, Verbraak FD, Vromans JGF, Lau NC, Altemark A, Hoyng CB. van Asten F, et al. Among authors: de jong hesse y. Acta Ophthalmol. 2019 Mar;97(2):e323-e324. doi: 10.1111/aos.13946. Epub 2018 Oct 14. Acta Ophthalmol. 2019. PMID: 30318723 Free article. No abstract available.
18 results